Aslı Örmeci

507 total citations
42 papers, 333 citations indexed

About

Aslı Örmeci is a scholar working on Epidemiology, Surgery and Hepatology. According to data from OpenAlex, Aslı Örmeci has authored 42 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 15 papers in Surgery and 13 papers in Hepatology. Recurrent topics in Aslı Örmeci's work include Liver Disease Diagnosis and Treatment (12 papers), Inflammatory Bowel Disease (7 papers) and Hepatitis C virus research (7 papers). Aslı Örmeci is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Inflammatory Bowel Disease (7 papers) and Hepatitis C virus research (7 papers). Aslı Örmeci collaborates with scholars based in Türkiye, United States and Antigua and Barbuda. Aslı Örmeci's co-authors include Filiz Akyüz, Sabahattin Kaymakoğlu, Bülent Baran, Suut Göktürk, Kadir Demır, Fatih Beşışık, Sami Evirgen, Çetin Karaca, Mine Güllüoğlu and Murat Köse and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Scientific Reports.

In The Last Decade

Aslı Örmeci

36 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aslı Örmeci Türkiye 11 172 129 101 75 53 42 333
Laura Cristoferi Italy 13 172 1.0× 195 1.5× 257 2.5× 42 0.6× 21 0.4× 37 428
Suut Göktürk Türkiye 11 196 1.1× 141 1.1× 65 0.6× 19 0.3× 42 0.8× 31 303
Çağdaş Kalkan Türkiye 11 335 1.9× 305 2.4× 151 1.5× 22 0.3× 98 1.8× 54 513
Abdelrahman Kobtan Egypt 10 223 1.3× 256 2.0× 120 1.2× 21 0.3× 40 0.8× 26 387
M P Manns Germany 9 189 1.1× 191 1.5× 150 1.5× 19 0.3× 59 1.1× 31 367
Bernhard Morell Switzerland 8 68 0.4× 23 0.2× 166 1.6× 24 0.3× 29 0.5× 24 260
Serag Esmat Egypt 9 120 0.7× 63 0.5× 86 0.9× 26 0.3× 28 0.5× 17 248
S Zeuzem Germany 10 228 1.3× 224 1.7× 63 0.6× 42 0.6× 11 0.2× 30 350
Nilesh Lodhia United States 8 92 0.5× 34 0.3× 158 1.6× 11 0.1× 124 2.3× 16 303
Zachary Zator United States 7 235 1.4× 32 0.2× 105 1.0× 12 0.2× 23 0.4× 10 307

Countries citing papers authored by Aslı Örmeci

Since Specialization
Citations

This map shows the geographic impact of Aslı Örmeci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aslı Örmeci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aslı Örmeci more than expected).

Fields of papers citing papers by Aslı Örmeci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aslı Örmeci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aslı Örmeci. The network helps show where Aslı Örmeci may publish in the future.

Co-authorship network of co-authors of Aslı Örmeci

This figure shows the co-authorship network connecting the top 25 collaborators of Aslı Örmeci. A scholar is included among the top collaborators of Aslı Örmeci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aslı Örmeci. Aslı Örmeci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Örmeci, Aslı, Arzu Poyanlı, Kürşat Serin, et al.. (2025). Inflammation and Immune-Based Scores Predict Prognosis for Patients with Hepatocellular Carcinoma: A Pilot Single-Center Study. The Turkish Journal of Gastroenterology. 36(4). 219–228. 1 indexed citations
2.
Baran, Bülent, Aslı Örmeci, Filiz Akyüz, et al.. (2025). Extra intestinal manifestations may increase the risk of synchronous and metachronous development of other extraintestinal manifestations in patients with Crohn’s disease. Scientific Reports. 15(1). 20629–20629. 1 indexed citations
3.
4.
Örmeci, Aslı, et al.. (2025). The role of GALAD score in the surveillance of hepatocellular carcinoma. Scientific Reports. 15(1). 22279–22279.
5.
6.
Genç, Sema, Mine Güllüoğlu, Aslı Örmeci, et al.. (2023). P316 Inflammatory Bowel Disease and malignancy: What are the predictors of malignancy in Inflammatory Bowel Disease?. Journal of Crohn s and Colitis. 17(Supplement_1). i456–i457.
7.
Karşıdağ, Kubilay, Aslı Örmeci, Filiz Akyüz, et al.. (2023). The liver worsens in non-alcoholic fatty liver disease patients as diabetes mellitus worsens and lasts longer. Journal of Hepatology. 78. S709–S710.
8.
Evirgen, Sami, Raım Iliaz, Filiz Akyüz, et al.. (2022). Cyclosporine Therapy as a Rescue Treatment in Steroid Refractory Acute Severe Ulcerative Colitis: A Real Life Data From a Tertiary Center. The Turkish Journal of Gastroenterology. 33(6). 463–469. 6 indexed citations
9.
Örmeci, Aslı, et al.. (2021). OKÜLT HEPATİT B VİRÜSÜNÜN GENOTİP, SUBGENOTİP VE SUBTİP ANALİZİ. SHILAP Revista de lepidopterología. 84(3). 402–410. 1 indexed citations
10.
Örmeci, Aslı, et al.. (2020). The effect of liver test abnormalities on the prognosis of COVID-19. Annals of Hepatology. 19(6). 614–621. 53 indexed citations
11.
Kayar, Yusuf, Bülent Baran, Aslı Örmeci, et al.. (2019). Risk factors associated with progression to intestinal complications of Crohn disease. Chinese Medical Journal. 132(20). 2423–2429. 8 indexed citations
12.
Iliaz, Raım, Filiz Akyüz, Gülçin Yeğen, et al.. (2018). Does the number of mucosal immune cells differ in irritable bowel syndrome and its subtypes?. The Turkish Journal of Gastroenterology. 29(4). 384–391. 2 indexed citations
13.
Baran, Bülent, Aslı Örmeci, Suut Göktürk, et al.. (2018). Current state and clinical outcome in Turkish patients with hepatocellular carcinoma. World Journal of Hepatology. 10(1). 51–61. 6 indexed citations
14.
Örmeci, Aslı, Yücel Aydın, Abdullah Şumnu, et al.. (2016). Predictors of treatment requirement in HBeAg-negative chronic hepatitis B patients with persistently normal alanine aminotransferase and high serum HBV DNA levels. International Journal of Infectious Diseases. 52. 68–73. 17 indexed citations
15.
Örmeci, Aslı, Filiz Akyüz, Bülent Baran, et al.. (2016). What is the impact of capsule endoscopy in the long term period?. World Journal of Gastrointestinal Endoscopy. 8(7). 344–344. 12 indexed citations
16.
Emre, Yılmaz, Bülent Baran, Mustafa Önel, et al.. (2014). Effects of Polymorphisms in Interferon λ 3 (Interleukin 28B) on Sustained Virologic Response to Therapy in Patients With Chronic Hepatitis D Virus Infection. Clinical Gastroenterology and Hepatology. 12(10). 1753–1758. 9 indexed citations
17.
Akyüz, Filiz, Suut Göktürk, Sami Evirgen, et al.. (2014). Small bowel mucosal damage in familial Mediterranean fever: results of capsule endoscopy screening. Scandinavian Journal of Gastroenterology. 49(12). 1414–1418. 18 indexed citations
18.
Karabulut, Senem, Faruk Taş, Filiz Akyüz, et al.. (2013). Clinical significance of serum hepatocyte growth factor (HGF) levels in hepatocellular carcinoma. Tumor Biology. 35(3). 2327–2333. 16 indexed citations
19.
Gül, Mehmet, et al.. (2012). Treatment of aortic valve stenosis and gastrointestinal bleeding by transcatheter aortic valve implantation in Heyde syndrome. Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology. 12(8). 691–3. 7 indexed citations
20.
Karaca, Çetin, Bülent Baran, Aslı Örmeci, et al.. (2012). Efficacy of peginterferon alpha treatment for 24 months in chronic delta hepatitis and predictors of response. Antiviral Therapy. 18(4). 561–566. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Cristoferi Breakdown of academic impact, for papers by Suut Göktürk Breakdown of academic impact, for papers by Çağdaş Kalkan Breakdown of academic impact, for papers by Abdelrahman Kobtan Breakdown of academic impact, for papers by M P Manns Breakdown of academic impact, for papers by Bernhard Morell Breakdown of academic impact, for papers by Serag Esmat Breakdown of academic impact, for papers by S Zeuzem Breakdown of academic impact, for papers by Nilesh Lodhia Breakdown of academic impact, for papers by Zachary Zator
Rankless by CCL
2026